David O'Donnell1,2, Brian Wisnoskey3, Nima Badie4, Lisa Odgers4, Taylah Smart5, Michelle Ord5,6, Tina Lin5, Jan O Mangual4, Gary Cranke3, Luke C McSpadden4, Kyungmoo Ryu4, Valter Bianchi7, Antonio D'Onofrio7, Carlo Pappone8, Leonardo Calò9, Anthony Chow10, Tim R Betts11, Bernard Thibault12, Niraj Varma13. 1. GenesisCare Cardiology, Burgundy Street, Heidelberg, Victoria, 3084, Australia. odonnell_research@hotmail.com. 2. Austin Hospital, Heidelberg, Australia. odonnell_research@hotmail.com. 3. Abbott, Cleveland, OH, USA. 4. Abbott, Sylmar, CA, USA. 5. GenesisCare Cardiology, Burgundy Street, Heidelberg, Victoria, 3084, Australia. 6. Austin Hospital, Heidelberg, Australia. 7. Department of Cardiology, Monaldi Hospital, Naples, Italy. 8. Department of Arrhythmology, I.R.C.C.S. Policlinico San Donato, San Donato Milanese, Italy. 9. Policlinico Casilino, Rome, Italy. 10. Barts Heart Centre, St. Bartholomew's Hospital, London, UK. 11. Cardiology Department, Oxford University Hospital, Oxford, UK. 12. Montreal Heart Institute, Montreal, Canada. 13. Cleveland Clinic, Cleveland, OH, USA.
Abstract
PURPOSE: Multipoint pacing (MPP) improves left ventricular (LV) electrical synchrony in cardiac resynchronization therapy (CRT). SyncAV automatically adjusts atrioventricular delay (AVD) according to intrinsic AV intervals and may further improve synchrony. Their combination has not been assessed. The objective was to evaluate the improvement in electrical synchrony achieved by SyncAV combined with MPP in an international, multicenter study. METHODS: Patients with LBBB undergoing CRT implant with a quadripolar lead (Abbott Quartet™) were prospectively enrolled. QRS duration (QRSd) was measured by blinded observers from 12-lead ECG during: intrinsic conduction, BiV pacing (conventional biventricular pacing, nominal static AVD), MPP (2 LV cathodes maximally spaced, nominal static AVD), BiV + SyncAV, and MPP + SyncAV. All SyncAV offsets were individualized for each patient to yield the narrowest QRSd during BiV pacing. QRSd changes were compared by ANOVA and post hoc Tukey-Kramer tests. RESULTS: One hundred and three patients were enrolled (65.7 ± 12.1 years, 67% male, 37% ischemic, EF 26.4 ± 6.5%, PR 190.3 ± 39.1 ms). Relative to intrinsic conduction (QRSd of 165 ± 16 ms), BiV reduced QRSd by 11.9% to 145 ± 18 ms (P < 0.001 vs intrinsic), and MPP reduced QRSd by 13.3% to 142 ± 19 ms (P < 0.001 vs intrinsic). However, enabling SyncAV with a patient-optimized offset nearly doubled this QRSd reduction. BiV + SyncAV reduced QRSd by 22.0% to 128 ± 13 ms (P < 0.001 vs BiV), while MPP + SyncAV reduced QRSd further by 25.6% to 122 ± 14 ms (P < 0.05 vs BiV + SyncAV). CONCLUSION: SyncAV can significantly improve acute electrical synchrony beyond conventional CRT, with further improvement achieved by superimposing MPP.
PURPOSE: Multipoint pacing (MPP) improves left ventricular (LV) electrical synchrony in cardiac resynchronization therapy (CRT). SyncAV automatically adjusts atrioventricular delay (AVD) according to intrinsic AV intervals and may further improve synchrony. Their combination has not been assessed. The objective was to evaluate the improvement in electrical synchrony achieved by SyncAV combined with MPP in an international, multicenter study. METHODS:Patients with LBBB undergoing CRT implant with a quadripolar lead (Abbott Quartet™) were prospectively enrolled. QRS duration (QRSd) was measured by blinded observers from 12-lead ECG during: intrinsic conduction, BiV pacing (conventional biventricular pacing, nominal static AVD), MPP (2 LV cathodes maximally spaced, nominal static AVD), BiV + SyncAV, and MPP + SyncAV. All SyncAV offsets were individualized for each patient to yield the narrowest QRSd during BiV pacing. QRSd changes were compared by ANOVA and post hoc Tukey-Kramer tests. RESULTS: One hundred and three patients were enrolled (65.7 ± 12.1 years, 67% male, 37% ischemic, EF 26.4 ± 6.5%, PR 190.3 ± 39.1 ms). Relative to intrinsic conduction (QRSd of 165 ± 16 ms), BiV reduced QRSd by 11.9% to 145 ± 18 ms (P < 0.001 vs intrinsic), and MPP reduced QRSd by 13.3% to 142 ± 19 ms (P < 0.001 vs intrinsic). However, enabling SyncAV with a patient-optimized offset nearly doubled this QRSd reduction. BiV + SyncAV reduced QRSd by 22.0% to 128 ± 13 ms (P < 0.001 vs BiV), while MPP + SyncAV reduced QRSd further by 25.6% to 122 ± 14 ms (P < 0.05 vs BiV + SyncAV). CONCLUSION: SyncAV can significantly improve acute electrical synchrony beyond conventional CRT, with further improvement achieved by superimposing MPP.
Authors: Peter H Waddingham; Jan Mangual; Michele Orini; Nima Badie; Luke McSpadden; Pier D Lambiase; Anthony W C Chow Journal: HeartRhythm Case Rep Date: 2021-09-29